Iridex (IRIX) Cash from Financing Activities (2011 - 2026)
Iridex (IRIX) recorded quarterly Cash from Financing Activities of -$1000.0 in Q2 2026, up 96.3% quarter-over-quarter from -$27000.0 in Q1 2026, and down 100.02% on a YoY basis from $6.0 million in Q2 2025.
Iridex (IRIX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Iridex's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at -$1000.0 for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 100.02% year-over-year to -$1000.0; the TTM figure through Apr 2026 stood at -$76000.0 (down 100.88% YoY), while the FY2026 annual figure was $6.0 million, up 128.94% from the prior year.
- Cash from Financing Activities was -$1000.0 for Q2 2026 at Iridex, up from -$27000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $7.0 million in Q1 2022 to a low of -$218000.0 in Q4 2024.
- Historically, Cash from Financing Activities has averaged $1.0 million across 5 years, with a median of -$14000.0 in 2025.
- Biggest YoY gain for Cash from Financing Activities was 11862.5% in 2024; the steepest drop was 584.44% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$26000.0 in 2022, then soared by 273.08% to $45000.0 in 2023, then sank by 584.44% to -$218000.0 in 2024, then jumped by 84.4% to -$34000.0 in 2025, then soared by 97.06% to -$1000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$1000.0 (Q2 2026), -$27000.0 (Q1 2026), and -$34000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -1,000.00 |
| Apr 4, 2026 | -1,000.00 |
| Jan 3, 2026 | -27,000.00 |
| Jan 3, 2026 | -27,000.00 |
| Sep 27, 2025 | -34,000.00 |
| Sep 27, 2025 | -34,000.00 |
| Jun 28, 2025 | -14,000.00 |
| Jun 28, 2025 | -14,000.00 |
| Mar 29, 2025 | 6.04 Mn |
| Mar 29, 2025 | 6.04 Mn |
| Dec 28, 2024 | -218,000.00 |
| Dec 28, 2024 | -218,000.00 |
| Sep 28, 2024 | 2.82 Mn |
| Sep 28, 2024 | 2.82 Mn |
| Dec 30, 2023 | 45,000.00 |
| Dec 30, 2023 | 45,000.00 |
| Sep 30, 2023 | -24,000.00 |
| Sep 30, 2023 | -24,000.00 |
| Jul 1, 2023 | -63,000.00 |
| Jul 1, 2023 | -63,000.00 |